PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2360.0
(0.0%)
IDR 2360.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 872.14 Billion IDR | -19.7% |
| 2022 | 1084.61 Billion IDR | 3.25% |
| 2021 | 1050.47 Billion IDR | 27.06% |
| 2020 | 826.74 Billion IDR | 3.05% |
| 2019 | 802.24 Billion IDR | -8.2% |
| 2018 | 873.9 Billion IDR | 27.6% |
| 2017 | 684.88 Billion IDR | -8.95% |
| 2016 | 752.19 Billion IDR | 2.01% |
| 2015 | 737.37 Billion IDR | 10.46% |
| 2014 | 667.56 Billion IDR | 8.21% |
| 2013 | 616.92 Billion IDR | 14.92% |
| 2012 | 536.83 Billion IDR | 14.46% |
| 2011 | 469.01 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 253.98 Billion IDR | 100.46% |
| 2024 Q1 | 345.61 Billion IDR | 88.45% |
| 2024 Q2 | 126.69 Billion IDR | -63.34% |
| 2023 Q3 | 255.24 Billion IDR | 138.38% |
| 2023 FY | 870.91 Billion IDR | -19.7% |
| 2023 Q1 | 347.39 Billion IDR | 55.5% |
| 2023 Q2 | 107.07 Billion IDR | -69.18% |
| 2023 Q4 | 183.4 Billion IDR | -28.15% |
| 2022 Q1 | 338.23 Billion IDR | 64.66% |
| 2022 FY | 1084.61 Billion IDR | 3.25% |
| 2022 Q4 | 223.4 Billion IDR | -28.84% |
| 2022 Q3 | 313.95 Billion IDR | 50.21% |
| 2022 Q2 | 209.01 Billion IDR | -38.2% |
| 2021 Q3 | 312.19 Billion IDR | 31.97% |
| 2021 Q2 | 236.57 Billion IDR | -20.15% |
| 2021 Q4 | 205.41 Billion IDR | -34.2% |
| 2021 Q1 | 296.28 Billion IDR | 21.16% |
| 2021 FY | 1050.47 Billion IDR | 27.06% |
| 2020 Q1 | 213.63 Billion IDR | 21.89% |
| 2020 FY | 826.74 Billion IDR | 3.05% |
| 2020 Q2 | 209.12 Billion IDR | -2.12% |
| 2020 Q3 | 159.44 Billion IDR | -23.75% |
| 2020 Q4 | 244.53 Billion IDR | 53.36% |
| 2019 FY | 802.24 Billion IDR | -8.2% |
| 2019 Q3 | 198.9 Billion IDR | -18.37% |
| 2019 Q4 | 175.27 Billion IDR | -11.88% |
| 2019 Q1 | 184.4 Billion IDR | -23.71% |
| 2019 Q2 | 243.65 Billion IDR | 32.13% |
| 2018 Q2 | 223.62 Billion IDR | 38.09% |
| 2018 Q1 | 161.94 Billion IDR | -30.7% |
| 2018 Q4 | 241.71 Billion IDR | -1.99% |
| 2018 FY | 873.9 Billion IDR | 27.6% |
| 2018 Q3 | 246.62 Billion IDR | 10.28% |
| 2017 Q2 | 198.59 Billion IDR | 55.46% |
| 2017 FY | 684.88 Billion IDR | -8.95% |
| 2017 Q4 | 233.69 Billion IDR | 87.21% |
| 2017 Q3 | 124.83 Billion IDR | -37.14% |
| 2017 Q1 | 127.75 Billion IDR | -47.69% |
| 2016 Q4 | 244.21 Billion IDR | 62.77% |
| 2016 FY | 752.19 Billion IDR | 2.01% |
| 2016 Q3 | 150.03 Billion IDR | -19.0% |
| 2016 Q2 | 185.21 Billion IDR | 7.23% |
| 2016 Q1 | 172.72 Billion IDR | -18.62% |
| 2015 FY | 737.37 Billion IDR | 10.46% |
| 2015 Q4 | 212.25 Billion IDR | -2.47% |
| 2015 Q3 | 217.63 Billion IDR | 23.34% |
| 2015 Q2 | 176.45 Billion IDR | 34.66% |
| 2015 Q1 | 131.03 Billion IDR | -34.05% |
| 2014 FY | 667.56 Billion IDR | 8.21% |
| 2014 Q4 | 198.7 Billion IDR | 15.16% |
| 2014 Q3 | 172.54 Billion IDR | -1.13% |
| 2014 Q2 | 174.52 Billion IDR | 43.31% |
| 2014 Q1 | 121.78 Billion IDR | -46.26% |
| 2013 Q4 | 226.61 Billion IDR | 130.91% |
| 2013 FY | 616.92 Billion IDR | 14.92% |
| 2013 Q1 | 107.91 Billion IDR | -48.91% |
| 2013 Q2 | 184.25 Billion IDR | 70.74% |
| 2013 Q3 | 98.13 Billion IDR | -46.74% |
| 2012 Q1 | 101.51 Billion IDR | 0.0% |
| 2012 FY | 536.83 Billion IDR | 14.46% |
| 2012 Q3 | 121.03 Billion IDR | 17.46% |
| 2012 Q4 | 211.23 Billion IDR | 74.52% |
| 2012 Q2 | 103.04 Billion IDR | 1.5% |
| 2011 FY | 469.01 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 26.79 Billion IDR | -3154.917% |
| PT Kimia Farma (Persero) Tbk | -1570.24 Billion IDR | 155.542% |
| PT Millennium Pharmacon International Tbk | 105.39 Billion IDR | -727.476% |
| PT Soho Global Health Tbk | 438.67 Billion IDR | -98.815% |